VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
TGTX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
TGTXTG Therapeutics, Inc.
$53.52$8.2B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksTGTXPrice History

TGTX logoTG Therapeutics, Inc. (TGTX) Stock Price History

Historical prices from 2010 to 2026

$53.52-1.42  (-2.58%)close Jul 1
Returns
1M
+30.7%
3M
+58.9%
YTD
+82.8%
1Y
+48.7%
3Y
+32.4%
5Y
+6.6%
ATH$233.44May 2010-77.1%
ATL$0.96Dec 2011pre-split
Avg Vol (50D)2.2M/ day
52-Week Range$25.28 — $57.38
LowCurrent: $53.52High

Loading 10-year price history...

TGTX Historical Performance

1 YearTotal Return
+48.7%
Price: +48.7%
3 YearsTotal Return
+132.3%
CAGR: +32.4%
Price: +132.3%
5 YearsTotal Return
+37.7%
CAGR: +6.6%
Price: +37.7%
YTD
+82.8%

TGTX Annual Returns

Year-by-year price performance · 2010–2026

Best+375.9%2020
Worst-97.9%2011
Up years9/17
2010-77.5%
2011-97.9%
2012+222.1%
2013+5.4%
2014+286.3%
2015-26.9%
2016-59.2%
2017+84.3%
2018-53.1%
2019+157.5%
2020+375.9%
2021-62.7%
2022-42.2%
2023+47.6%
2024+76.6%
2025-4.0%
2026+2.8%
2010 annual price return
-77.5%
2011 annual price return
-97.9%
2012 annual price return
+222.1%
2013 annual price return
+5.4%
2014 annual price return
+286.3%
2015 annual price return
-26.9%
2016 annual price return
-59.2%
2017 annual price return
+84.3%
2018 annual price return
-53.1%
2019 annual price return
+157.5%
2020 annual price return
+375.9%
2021 annual price return
-62.7%
2022 annual price return
-42.2%
2023 annual price return
+47.6%
2024 annual price return
+76.6%
2025 annual price return
-4.0%
2026 annual price return
+2.8%
LessMore
Alpha vs S&P 500
1Y+22.9%
3Y+12.4%
5Y-4.2%

Price returns only.

Download Historical Data

4,067 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

TGTX Stock Price Trajectory (2010–2026)

As of July 7, 2026, TG Therapeutics, Inc. (TGTX) trades at $53.52, representing a +48.7% return over the past year. The stock has delivered a +37.7% total return over five years (+6.6% CAGR), reflecting significant long-term value creation.

The stock reached its all-time high of $233.44 on May 6, 2010. From this peak, TGTX has corrected -77.1%, currently trading 55% above its 200-day moving average, indicating continued institutional support.

When compared to Healthcare sector peers RCUS (+264.7% 1Y), IMVT (+135.1% 1Y), and PRAX (+571.6% 1Y), TGTX has underperformed the peer group average. Compare TGTX vs RCUS →

TGTX Historical Price Data · from 2010

Rows 1–50 of 4,067
Date Open High Low Close Volume Change %
2026-07-0155.1055.4453.5053.521.98M-2.58%
2026-06-3055.8956.5654.5054.942.47M-1.40%
2026-06-2955.3256.7454.7955.72808K-0.20%
2026-06-2653.9756.7453.6855.830+4.10%
2026-06-2553.7055.1453.1853.631.84M+0.06%
2026-06-2453.9355.0353.2053.602.70M-0.63%
2026-06-2353.8555.5252.7053.942.72M-0.85%
2026-06-2254.9557.3854.2454.403.89M+2.22%
2026-06-1852.2354.0751.9653.227.15M+3.34%
2026-06-1750.8853.9850.6051.503.60M+1.90%
2026-06-1650.4150.8049.0050.541.93M+0.48%
2026-06-1549.0050.6048.0350.302.57M+1.58%
2026-06-1248.0550.4147.9849.522.53M+3.06%
2026-06-1146.6248.7446.1648.052.44M+3.07%
2026-06-1043.7349.3043.0146.625.07M+7.49%
2026-06-0942.4943.4541.5543.372.12M+5.91%
2026-06-0840.1241.9440.1240.951.49M+1.97%
2026-06-0540.5441.0840.0540.161.75M-0.99%
2026-06-0440.5842.4840.1040.561.99M+1.12%
2026-06-0338.6541.3437.9640.113.62M+9.47%
2026-06-0236.8537.2936.4836.641.04M-2.06%
2026-06-0137.5538.1936.8037.411.61M-1.40%
2026-05-2938.8139.2937.8437.941.15M-2.27%
2026-05-2839.0039.3438.5538.821.04M-0.97%
2026-05-2740.2840.5039.2039.201.52M-1.33%
2026-05-2639.0240.1038.7339.731.24M+2.21%
2026-05-2239.3339.3338.8738.871.20M-0.92%
2026-05-2139.4839.7538.8139.231.16M-1.33%
2026-05-2039.5740.6439.5139.761.37M+0.84%
2026-05-1938.8139.8938.2039.431.19M-0.13%
2026-05-1839.9439.9438.8339.481.57M-0.05%
2026-05-1540.3640.5239.4239.501.72M-3.16%
2026-05-1442.5042.7040.7640.791.52M-4.36%
2026-05-1342.4743.0741.9442.651.76M+0.26%
2026-05-1243.2344.0042.2842.542.37M-1.39%
2026-05-1142.3743.1841.1143.142.76M+0.65%
2026-05-0843.0244.6542.2642.863.32M-0.38%
2026-05-0740.5844.0040.5843.024.19M+2.51%
2026-05-0636.2542.0336.2541.976.10M+16.26%
2026-05-0535.9836.2834.8736.101.36M+1.11%
2026-05-0433.7836.0833.7835.701.92M+5.48%
2026-05-0133.8634.0533.2333.851.47M+0.21%
2026-04-3033.5834.2433.3933.781.37M+0.60%
2026-04-2934.0234.1933.2833.581.80M-2.89%
2026-04-2835.6935.7534.4834.582.23M-2.26%
2026-04-2736.7136.9234.9835.381.61M-3.39%
2026-04-2436.8937.1536.3136.621.35M-0.81%
2026-04-2338.3438.3736.6136.921.86M-3.63%
2026-04-2236.4838.3136.2638.312.25M+5.60%
2026-04-2136.9437.2436.0736.282.08M-1.84%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

TGTX — Frequently Asked Questions

Quick answers to the most common questions about buying TGTX stock.

How has TGTX stock performed recently?

TGTX returned +48.7% over the past year, beating its 5-year annualized CAGR of +6.6%. The stock trades above its 200-day moving average, confirming the uptrend.

What is TGTX's all-time high price?

TG Therapeutics, Inc. reached $233.44 on 2010-05-06. The 52-week high is $57.38. Current 1-year return of +48.7% places the stock closer to historical peaks.

Where can I download TGTX historical price data?

This page provides TGTX daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2010-2026, downloadable in CSV format.

453 data points · sampled from 4,067